112 related articles for article (PubMed ID: 19504003)
1. Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats.
Baracho NC; Guizelli GP; Carmello BL; Sanches Dde S; Silva FM; Reis JM; Brito Jd
Acta Cir Bras; 2009; 24(3):206-10. PubMed ID: 19504003
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment.
Katyal J; Kumar H; Gupta YK
Epilepsy Behav; 2015 Mar; 44():98-103. PubMed ID: 25660085
[TBL] [Abstract][Full Text] [Related]
3. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y; Youssef S; Ahmed I; El Gaafary M
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
[TBL] [Abstract][Full Text] [Related]
4. Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats.
Fracon RN; Teófilo JM; Moris IC; Lamano T
J Appl Oral Sci; 2010 Dec; 18(6):630-4. PubMed ID: 21308296
[TBL] [Abstract][Full Text] [Related]
5. [Effect of nonsteroidal anti-inflammatory drugs on the indicators of cardiovascular risk in patients with acute nonspecific back pain].
Zolotovskaya IA; Davydkin IL
Ter Arkh; 2015; 87(12):18-25. PubMed ID: 26978413
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol.
Moraes BM; do Amaral BC; Morimoto MS; Vieira LG; Perazzo FF; Carvalho JC
Inflammopharmacology; 2007 Aug; 15(4):175-8. PubMed ID: 17701021
[TBL] [Abstract][Full Text] [Related]
7. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Brattwall M; Turan I; Jakobsson J
Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
[TBL] [Abstract][Full Text] [Related]
9. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.
Greenwald M; Peloso PM; Mandel D; Soto O; Mehta A; Frontera N; Boice JA; Zhan XJ; Curtis SP
Curr Med Res Opin; 2011 Oct; 27(10):2033-42. PubMed ID: 21905970
[TBL] [Abstract][Full Text] [Related]
10. Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers.
Agrawal NG; Porras AG; Matthews CZ; Woolf EJ; Miller JL; Mukhopadhyay S; Neu DC; Gottesdiener KM
J Clin Pharmacol; 2001 Oct; 41(10):1106-10. PubMed ID: 11583479
[TBL] [Abstract][Full Text] [Related]
11. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
[No Abstract] [Full Text] [Related]
12. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K
J Clin Pharmacol; 2009 Oct; 49(10):1202-9. PubMed ID: 19783714
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model.
Daniels SE; Bandy DP; Christensen SE; Boice J; Losada MC; Liu H; Mehta A; Peloso PM
Clin J Pain; 2011 Jan; 27(1):1-8. PubMed ID: 21188849
[TBL] [Abstract][Full Text] [Related]
14. Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
Viscusi ER; Frenkl TL; Hartrick CT; Rawal N; Kehlet H; Papanicolaou D; Gammaitoni A; Ko AT; Morgan LM; Mehta A; Curtis SP; Peloso PM
Curr Med Res Opin; 2012 Aug; 28(8):1323-35. PubMed ID: 22738802
[TBL] [Abstract][Full Text] [Related]
15. A case report on toxic epidermal necrolysis with etoricoxib.
Kameshwari JS; Devde R
Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
[TBL] [Abstract][Full Text] [Related]
16. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
Wong EH; Leung TW; Wong KS
J Neuroimaging; 2007 Jan; 17(1):87-8. PubMed ID: 17238877
[TBL] [Abstract][Full Text] [Related]
17. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibition by etoricoxib modulates plasma membrane fluidity in rat colon.
Behal N; Kanwar SS; Kaur J; Sanyal SN
J Environ Pathol Toxicol Oncol; 2008; 27(4):295-302. PubMed ID: 19105535
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.
Krum H; Swergold G; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP
J Hypertens; 2009 Apr; 27(4):886-93. PubMed ID: 19516186
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and cardiovascular effect of etoricoxib in the absence or presence of St. John's Wort in rats.
Radwan MA; Baky NA; Zaghloul I; Aboul-Enein HY
Arzneimittelforschung; 2012 Jul; 62(7):313-8. PubMed ID: 22549240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
